 This is an open-label, comparative, randomized, parallel, multicenter study in asthmatics to determine whether the administration of dry powder inhaled mometasone furoate MF 400 μg in a monodose capsule device would be comparable to administration of powder inhaled MF 400 μg in a multidose device. 